Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether doses of 30 mg and 45 mg AZD2171 can be
well tolerated without significant drug withdrawal when accompanied by a suitable
hypertension management strategy or dose reduction.